Topics

Divide & Conquer Company Profile

18:15 EST 24th January 2020 | BioPortfolio

About Cellular Parabiosis


News Articles [77 Associated News Articles listed on BioPortfolio]

Precision Oncology in Sarcomas: Divide and Conquer

How is next-generation sequencing changing the landscape of diagnosis and treatment of sarcoma? JCO Precision Oncology

Lilly announces positive results for Emgality from CONQUER study

The CONQUER study was designed and conducted based on findings from subgroup analyses of prior Phase 3 studies of Emgality, which suggested it may be an option for The post Lilly announces positive r...

Lilly reports positive data from CONQUER study of Emgality

Eli Lilly and Company has reported positive data from the Phase III CONQUER study of Emgality (galcanezumab-gnlm) in patients who...Read More... The post Lilly reports positive data from CONQUER study...

World's largest road hockey fundraiser raises $3.1 million to conquer cancer

More than 1,900 participants, making up 167 teams, faced off today at Woodbine Racetrack in Toronto and raised a record-breaking $3.1 million as part of the 9th annual Scotiabank Road Hockey to Conque...

Rice, Amazon report breakthrough in ‘distributed deep learning’

Online shoppers typically string together a few words to search for the product they want, but in a world with millions of products and shoppers, the task of matching those unspecific words to the rig...

Lilly Says Emgality Meets Primary And Secondary Outcomes In CONQUER Study

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) said that Emgality or galcanezumab met the primary and all key secondary outcomes in CONQUER, a late-stage study evaluating the efficacy and safety...

Both Sides of Abortion Divide Get Their Say at House Hearing

]]>(MedPage Today) -- WASHINGTON -- The deep partisan divide over abortion was on full display at Thursday's House Oversight and Reform Committee hearing on state restrictions of women's reproductiv...

How to divide and conquer -F-star’s asset centric business model and their recent big deal with BMS.

F-star develops novel bispecific antibodies to improve the treatment of serious diseases, with a focus on immuno-oncology and inflammation. John Haurum explains to PharmaVentures' Adrian Dawkes how th...

Drugs and Medications [5 Associated Drugs and Medications listed on BioPortfolio]

Azacitidine [cipla usa inc.]

These highlights do not include all the information needed to use AZACITIDINE FOR INJECTION safely and effectively. See full prescribing information for AZACITIDINE FOR INJECTION.AZACITIDINE for injec...

Azacitidine [northstar rxllc]

These highlights do not include all the information needed to use AZACITIDINE FOR INJECTION safely and effectively. See full prescribing information for AZACITIDINE FOR INJECTION.AZACITIDINE for injec...

Vidaza [celgene corporation]

These highlights do not include all the information needed to use VIDAZA safely and effectively. See full prescribing information for VIDAZA. VIDAZA (azacitidine for injection), for subcutaneous or in...

Azacitidine [dr. reddy's laboratories inc.]

These highlights do not include all the information needed to use AZACITIDINE FOR INJECTION safely and effectively. See full prescribing information for AZACITIDINE FOR INJECTION.  AZACITIDINE for in...

Azacitidine [dr. reddy's laboratories inc.]

These highlights do not include all the information needed to use AZACITIDINE FOR INJECTION safely and effectively. See full prescribing information for AZACITIDINE FOR INJECTION.  AZACITIDINE for in...

PubMed Articles [63 Associated PubMed Articles listed on BioPortfolio]

A fast divide-and-conquer sparse Cox regression.

We propose a computationally and statistically efficient divide-and-conquer (DAC) algorithm to fit sparse Cox regression to massive datasets where the sample size $n_0$ is exceedingly large and the co...

Debiasing and Distributed Estimation for High-Dimensional Quantile Regression.

Distributed and parallel computing is becoming more important with the availability of extremely large data sets. In this article, we consider this problem for high-dimensional linear quantile regress...

Likelihood Inference for Large Scale Stochastic Blockmodels with Covariates based on a Divide-and-Conquer Parallelizable Algorithm with Communication.

We consider a stochastic blockmodel equipped with node covariate information, that is helpful in analyzing social network data. The key objective is to obtain maximum likelihood estimates of the model...

A Divide-and-Conquer Approach to Compressed Sensing MRI.

Compressed sensing (CS) theory assures us that we can accurately reconstruct magnetic resonance images using fewer k-space measurements than the Nyquist sampling rate requires. In traditional CS-MRI i...

TreeCluster: Clustering biological sequences using phylogenetic trees.

Clustering homologous sequences based on their similarity is a problem that appears in many bioinformatics applications. The fact that sequences cluster is ultimately the result of their phylogenetic ...

Clinical Trials [127 Associated Clinical Trials listed on BioPortfolio]

Corneal Edema After Phacoemulsification

To compare the impact of two phacoemulsification techniques (subluxation versus divide-and-conquer) on postoperative corneal edema at postoperative hour 1 and day 4.

Endothelial Cell Loss After Phacoemulsification Intra and Supracapsular

Cataract is the clouding of the lens of the eye, which initially prevents clear vision and eventually progresses to blindness if left untreated. Cataract remains the leading cause of blind...

Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer

This trial will pilot a psychosocial intervention called Conquer Fear Support (CFS) in patients with stage III-IV lung or gynecologic cancer who are experiencing fear of cancer progression...

Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma

Velcade (bortezomib, PS-341) has recently been approved by the Food and Drug Administration (FDA) for the treatment of multiple myeloma (MM) for patients who have received at least one pri...

Metformin SR Tablet (DuLeNing) and Glucophage in Patients With Type 2 Diabetes

Metformin hydrochloride sustained-release tablets made in Conquer pharmaceutical co., LTD is approved by China Food And Drug Administration (cFDA). Whether its efficacy and safety are equa...

Companies [10 Associated Companies listed on BioPortfolio]

Divide & Conquer

About Cellular Parabiosis

Asterand Incorporated

Asterand’s mission is to help medical researchers in the genomics and proteomics industries conquer diseases. We provide the products and services necessary for the development of new diagnosti...

Babraham Bioscience Technologies Ltd

As the wholly-owned trading company of the Babraham Institute , Bioscience Technologies Limited (BBT) has developed a portfolio of commercial activities that has enabled us to engage more fully with i...

Interstitial Cystitis Association

Since its inception in 1984, the Interstitial Cystitis Association has remained the only nonprofit health association solely dedicated to providing advocacy, research funding, and education to ensure ...

Sierra Sciences, Inc

Sierra Sciences, Inc. (SSI) is a biotech research company located in Reno, Nevada. Our mission is to discover a medicine to prevent and/or reverse cellular senescence (the phenomenon where cells lose ...

More Information about "Divide & Conquer" on BioPortfolio

We have published hundreds of Divide & Conquer news stories on BioPortfolio along with dozens of Divide & Conquer Clinical Trials and PubMed Articles about Divide & Conquer for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Divide & Conquer Companies in our database. You can also find out about relevant Divide & Conquer Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record